Several studies, conducted in other cancer types, have suggested that patients responding to immunotherapy show abundant PD‐1+ T‐cell infiltration that co‐localizes with PD‐L1+ tumor or stromal cells 9. This evidence concerns the gene CD274 and neoplasm.